Skip to content
Who We Serve
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees
About Us
Our Team
Our Story
Investment Strategies
Who We Serve
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees
About Us
Our Team
Our Story
Investment Strategies
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees (911 Financial Services™)
Our Story
Our Team
Investment Strategies
Contact Us
Schwab Client Login
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees (911 Financial Services™)
Our Story
Our Team
Investment Strategies
Contact Us
Schwab Client Login
Contact Us
Schwab Client Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
266.77
+0.50 (+0.19%)
Streaming Delayed Price
Updated: 9:50 AM EDT, Sep 29, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about AbbVie
< Previous
1
2
3
4
5
6
7
8
9
Next >
A New Category Is Forming in Medical Aesthetics. Independent Research Has Started Sizing It.
August 18, 2026
From
Equity Insider
Via
GlobeNewswire
The GLP-1 Boom Created a Tissue Gap Fillers Were Not Built For
August 12, 2026
News Provided by USA News Group on behalf of Conexeu Sciences Inc.
From
USA News Group
Via
GlobeNewswire
Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One
August 04, 2026
Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)
From
American News Group
Via
GlobeNewswire
Genmab and AbbVie Provide Clarification on Phase 3 EPCORE® DLBCL-1 Trial Evaluating Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
July 23, 2026
From
Genmab A/S and AbbVie
Via
Business Wire
A Nasdaq-Listed Regenerative Tissue Company Just Opened a Lab: The Next Step in Scaling a Platform Built for a NEW Aesthetics Opportunity
July 01, 2026
From
Biotech Insider
Via
GlobeNewswire
The Aesthetics Giants Just Confirmed “Ozempic Face” Is Real — and a Newly Public Regenerative Player Wants to Compete for It
June 25, 2026
From
Biotech Insider
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Apogee Therapeutics, Inc. (Nasdaq – APGE), Simulations Plus, Inc. (Nasdaq – SLP), Roku, Inc. (Nasdaq – ROKU), TruBridge, Inc. (Nasdaq – TBRG)
June 22, 2026
From
Brodsky & Smith LLC
Via
GlobeNewswire
How Many Botox Units Do You Need: Forehead, Crow's Feet, and Frown Lines
June 18, 2026
Via
Press Release Distribution Service
CNS Drug Delivery Technologies Are Reshaping Alzheimer’s and Biodefense Research
May 13, 2026
Via
Investor Brand Network
Next-Generation GLP-1 Innovation Could Unlock Massive Metabolic Healthcare Market Opportunities
May 13, 2026
Via
Investor Brand Network
InvestorNewsBreaks – SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Featured in BioMedWire Editorial on Next-Generation GLP-1 Innovation
May 13, 2026
Via
Investor Brand Network
InvestorNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial on Next-Generation CNS Drug Delivery
May 13, 2026
Via
Investor Brand Network
Topics
Intellectual Property
Next-Generation GLP-1 Innovation Could Unlock Massive Metabolic Healthcare Market Opportunities
May 13, 2026
From
BioMedWire
Via
GlobeNewswire
Aqua Medical Spa Launches New Website to Showcase Aesthetic and Wellness Services in London, ON
May 01, 2026
Via
GetFeatured
CNS Drug Delivery Technologies Are Reshaping Alzheimer’s and Biodefense Research
May 13, 2026
From
BioMedWire
Via
GlobeNewswire
Growth in Non-Surgical Aesthetic Treatments Reported Across Tampa Bay Locations
April 21, 2026
Via
Press Release Distribution Service
Novel Serotonergic Agonists Positioned to Capture Share of $150B+ Neuropsychiatric Market
February 10, 2026
EQNX::TICKER_START (NASDAQ:HELP),(NYSE:JNJ),(NYSE:ABBV),(NYSE:TAK),(NYSE:AZN) EQNX::TICKER_END
Via
FinancialNewsMedia
AbbVie and Xilio Therapeutics Announce Collaboration and Option Agreement to Develop Novel Tumor-Activated Immunotherapies
February 12, 2025
From
Xilio Therapeutics, Inc.; AbbVie Inc.
Via
GlobeNewswire
Achievements and Progress Heading into 2025 for Oncology Treatments and Therapies Fuel an Optimistic Outlook
December 26, 2024
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:GSK),(NASDAQ:AZN),(NYSE:ABBV),(NASDAQ:CRDF) EQNX::TICKER_END
Via
FinancialNewsMedia
Achievements and Progress Heading into 2025 for Oncology Treatments and Therapies Fuel an Optimistic Outlook
December 26, 2024
From
FN Media Group LLC
Via
GlobeNewswire
Best Pharma Stocks for Long-Term Investors: Growth and Dividends
October 14, 2024
Big pharmaceutical firms may lack the potential for rally driven by a breakout drug like small biotechs, but stability and steady growth remain attractive.
Via
MarketBeat
AbbVie Stock Eyes New Highs: Analysts See Strong Growth Potential
October 11, 2024
AbbVie is tracking for a new high that may be reached before the end of the year. Acquisitions fuel the growth outlook, cash flow and capital returns.
Via
MarketBeat
Topics
Intellectual Property
Active Biotech Alert: FDA Approves 16 New Cancer Treatments as Global Cancer Rates Skyrocket
October 04, 2024
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:ABBV),(NASDAQ:BGNE),(NASDAQ:HCM),(NASDAQ:ELVN) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Transforming Alzheimer’s Treatment: Innovative Combinations to Boost Cognition
October 01, 2024
Via
Investor Brand Network
Transforming Alzheimer’s Treatment: Innovative Combinations to Boost Cognition
October 01, 2024
EQNX::TICKER_START (NYSE:ANVS),(NYSE:LLY),(NYSE:PFE),(NYSE:NVO),(NASDAQ:ABBV) EQNX::TICKER_END
Via
FinancialNewsMedia
AbbVie Stock Post Humira is Still an Attractive Stock to Hold
September 04, 2024
AbbVie's strategic diversification and strong financial position make it possible to sustain growth despite the perceived “Humira cliff.”
Via
MarketBeat
Topics
Intellectual Property
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth
September 04, 2024
EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:NVAX),(NASDAQ:RGNX),(NASDAQ:BNTX),(NYSE:ABBV) EQNX::TICKER_END
Via
FinancialNewsMedia
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth
September 04, 2024
From
FN Media Group LLC
Via
GlobeNewswire
3 Best Growth Stocks to Own for the Next 10 Years
August 28, 2024
When in doubt, zoom out; these three growth stocks have a history of strong performance that is likely to continue for the next 10 years
Via
MarketBeat
Topics
Economy
Lock in Gains: 3 Dividend Stocks Poised to Boost Payouts Soon
August 16, 2024
These three stocks have a long history of increasing their dividends and are likely to benefit from sector rotation on expectations of lower interest rates
Via
MarketBeat
Topics
Artificial Intelligence
Economy
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
